These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9838908)
1. [Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group--Cervical-Ovarian Cancer Group]. Noda K; Tanaka K; Ozaki M; Hirabayasi K; Hasegawa K; Nishiya I; Yakushiji M; Izumi R; Tomoda Y; Ogita Y; Sugimori H; Yamabe T; Kudo R; Yajima A; Terashima Y; Fujii S; Suzuoki Y; Okada H; Kono I; Ochiai K; Yamamoto T; Ikeda M; Umesaki N; Saito T; Niitani H Gan To Kagaku Ryoho; 1998 Nov; 25(13):2061-8. PubMed ID: 9838908 [TBL] [Abstract][Full Text] [Related]
2. [Late phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical cancer. ETP 21 Study Group--Cervical Cancer Group]. Ikeda M; Noda K; Hiura M; Tamaya T; Ozaki M; Hatae M; Ozawa M; Yamabe T; Tanaka K; Izumi R; Okada H; Ogita Y; Hoshiai H Gan To Kagaku Ryoho; 1998 Dec; 25(14):2249-57. PubMed ID: 9881082 [TBL] [Abstract][Full Text] [Related]
3. [Late phase II study with 21-consecutive-day oral administration of etoposide for malignant lymphoma]. Yoshida T; Takagi T; Shimoyama M; Mikuni C; Suzuki K; Egami K; Furusawa S; Nomura T; Mori M; Sugimoto T Gan To Kagaku Ryoho; 1994 Dec; 21(16):2793-801. PubMed ID: 7993116 [TBL] [Abstract][Full Text] [Related]
4. [Phase I clinical study of 21-consecutive-day oral administration of etoposide]. Noda K; Fukuoka M; Komatsu H; Hayashihara K; Ariyoshi Y; Tanaka K; Nakajima H; Terashima Y; Nagao K; Furuse K Gan To Kagaku Ryoho; 1994 Aug; 21(10):1633-9. PubMed ID: 8060139 [TBL] [Abstract][Full Text] [Related]
5. [Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)]. Gan No Rinsho; 1985 Jul; 31(8):944-52. PubMed ID: 4040986 [TBL] [Abstract][Full Text] [Related]
6. A phase I trial of prolonged oral etoposide and liposomal doxorubicin in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study. Rose PG; Rodriguez M; Walker J; Greer B; Fusco N; McGuire W Gynecol Oncol; 2002 Apr; 85(1):136-9. PubMed ID: 11925133 [TBL] [Abstract][Full Text] [Related]
7. Sequential prolonged oral topotecan and prolonged oral etoposide as second-line therapy in ovarian or peritoneal carcinoma: a phase I Gynecologic Oncology Group study. Rose PG; Markman M; Bell JG; Fusco NL Gynecol Oncol; 2006 Aug; 102(2):236-9. PubMed ID: 16412499 [TBL] [Abstract][Full Text] [Related]
8. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for cervical cancer of the uterus]. Noda K; Ikeda M; Yakushiji M; Nishimura H; Terashima Y; Sasaki H; Hata T; Kuramoto H; Tanaka K; Takahashi T Gan To Kagaku Ryoho; 1992 Jun; 19(6):885-92. PubMed ID: 1605666 [TBL] [Abstract][Full Text] [Related]
9. A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix. Morris M; Brader KR; Burke TW; Levenback CF; Gershenson DM Gynecol Oncol; 1998 Aug; 70(2):215-8. PubMed ID: 9740693 [TBL] [Abstract][Full Text] [Related]
10. Phase I/IIa study of combination chemotherapy with CKD-602 and cisplatin in patients with recurrent epithelial ovarian cancer. Kim HS; Kang SB; Seo SS; Han SS; Kim JW; Park NH; Kang SB; Lee HP; Song YS Ann N Y Acad Sci; 2009 Aug; 1171():627-34. PubMed ID: 19723113 [TBL] [Abstract][Full Text] [Related]
11. [A phase II study of NK171 (etoposide)]. Kimura K; Niitani H Gan To Kagaku Ryoho; 1985 Oct; 12(10):2011-7. PubMed ID: 2996442 [TBL] [Abstract][Full Text] [Related]
12. [A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group]. Kado M; Oshima S; Matsui Y; Shimokata K; Hara K; Kanda T; Shima K; Takenaka S Gan To Kagaku Ryoho; 1986 Jan; 13(1):116-21. PubMed ID: 3002282 [TBL] [Abstract][Full Text] [Related]
13. Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC). Alici S; Saip P; Eralp Y; Aydiner A; Topuz E Am J Clin Oncol; 2003 Aug; 26(4):358-62. PubMed ID: 12902885 [TBL] [Abstract][Full Text] [Related]
14. [Late phase II clinical study of amrubicin hydrochloride, a novel synthetic anthracycline derivative anticancer agent, for malignant lymphoma]. Akutsu M; Kano Y; Ogawa M; Miura A; Hirano M; Masaoka T; Tatsumi N Gan To Kagaku Ryoho; 2001 Nov; 28(12):1867-76. PubMed ID: 11729479 [TBL] [Abstract][Full Text] [Related]
15. Sequential intraperitoneal topotecan and oral etoposide chemotherapy in recurrent platinum-resistant ovarian carcinoma: results of a phase II trial. Sood AK; Lush R; Geisler JP; Shahin MS; Sanders L; Sullivan D; Buller RE; Sorosky JI Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6080-5. PubMed ID: 15447993 [TBL] [Abstract][Full Text] [Related]
16. [Phase II study of etoposide (VP-16) in the form of oral capsules for malignant lymphomas]. Konishi I; Kitani T; Nagai K; Kanamaru A; Kohsaki M; Masaoka T; Shibata H; Horiuchi A; Tsubaki K; Kawagoe H Gan To Kagaku Ryoho; 1985 Jul; 12(7):1482-6. PubMed ID: 4015122 [TBL] [Abstract][Full Text] [Related]
18. [TUT-7 early phase II clinical study for various solid tumors and hematologic malignancies]. Taguchi T; Wakui A; Niitani H; Furue H; Majima H; Ota K; Ariyoshi H; Hattori T; Sugimachi K; Tsukagoshi S Gan To Kagaku Ryoho; 1997 Aug; 24(10):1253-61. PubMed ID: 9279344 [TBL] [Abstract][Full Text] [Related]
19. [A phase II study of oral VP-16 in primary lung cancer]. Matsui Y; Ohshima S; Kado M; Nakayama M; Shimokata K; Sakai S; Ito F; Chikata E; Hara K; Kanda T Gan To Kagaku Ryoho; 1985 Sep; 12(9):1801-7. PubMed ID: 2994576 [TBL] [Abstract][Full Text] [Related]
20. [A late phase II clinical study of S-1 in patients with progressed, refractory breast cancer]. Saeki T; Takashima S; Sano M; Horikoshi N; Miura S; Shimizu S; Morimoto K; Kimura M; Taguchi T Gan To Kagaku Ryoho; 2004 Apr; 31(4):539-47. PubMed ID: 15114697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]